SAN DIEGO – The Mass Spectrometry Applications to the Clinical Laboratory annual meeting arrived this week in San Diego with mass spec-based clinical proteomics having made significant strides in the last year.

In October, for instance, Integrated Diagnostics launched its Xpresys Lung test, the first multiplexed proteomic test to go to market using multiple-reaction monitoring mass spec on a triple quadrupole instrument.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.